The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 154.80
Bid: 154.00
Ask: 154.80
Change: 0.40 (0.26%)
Spread: 0.80 (0.519%)
Open: 154.80
High: 155.20
Low: 153.80
Prev. Close: 154.40
IBST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Jun 2020 07:00

RNS Number : 7456O
Ibstock PLC
03 June 2020
 

Trading Update

Ibstock plc ('Ibstock' or the 'Group'), a leading manufacturer of clay bricks and concrete products in the United Kingdom, today issues a trading update for the five months ended 31 May 2020.

Trading performance

Sales volumes during the first 10 weeks of the year were, as anticipated, modestly below the comparative period as we entered 2020 against the backdrop of more subdued market conditions. The Group saw a sharp decline in sales volumes from late March as the Government measures to control the Covid-19 pandemic began to take effect and our construction and housebuilding customers closed sites. During April, volumes in our Clay division fell by around 90% year on year, whilst exposure to infrastructure and RMI markets meant that volumes in our Concrete division remained relatively more resilient during that period.

As the construction and housebuilding sectors have begun to return to work over recent weeks, trading conditions have started to improve. We have seen a modest recovery in clay brick sales although volumes currently remain around 70% below the comparative period. Concrete volumes are now at around 50% of those from the same period in 2019.

Overall, Group revenues for the three months to 31 March 2020 were down by approximately 10% compared to the comparative period, with a decline of around 75% in the two months to 31 May 2020.

Operations

As announced on 15 May 2020, the Group has developed new working practices and protocols which reflect the latest guidance from the Government and public health authorities. This has allowed the recommencement of production at approximately one third of our manufacturing sites in response to customer demand. The Group will keep demand levels under close review and is able to restart production at further manufacturing sites over the coming months as required.

The Group has taken significant action to address the challenges presented by Covid-19. These measures have included utilising the Government's Coronavirus Job Retention Scheme for a significant portion of colleagues during the shutdown period, reducing discretionary spend wherever possible and implementing a temporary salary reduction for the Board and the executive leadership team.

In addition, in order to ensure that the business remains well-positioned as it emerges from the current crisis, we are conducting a review of all operations. This review is expected to lead to a material reduction in the Group's fixed cost base, through selective site closures, changes in operating patterns and changes to the size and structure of support functions. We have entered into consultations with employees across the Group as part of a series of restructuring proposals, with up to 375 positions, representing around 15 per cent of the Group's total workforce, potentially impacted as a result of these actions.

Whilst the changes anticipated will ensure our business is adapted to the near-term industry demand outlook, we retain the flexibility to scale production back up, as and when demand recovers.

Financial position

In addition to actions taken to reduce costs, the Group is continuing to prioritise liquidity and the preservation of cash to enhance its financial resilience and flexibility in response to Covid-19. In particular, this has included close management of working capital and deferral of non-essential capital expenditure and tax payments as allowed by Government schemes. As a result, net debt at 31 May 2020 was approximately £105 million, primarily reflecting seasonal working capital movements early in the year, and the Group continues to have significant liquidity headroom within its £215 million revolving credit facility ("RCF"), which expires in March 2022.

To maintain financial flexibility, the Group has secured agreement from its lending banks for a number of amendments to covenant tests under the Group's RCF1. The Group is also pleased to announce that it has been confirmed as eligible in principle to access funding under the Covid Corporate Financing Facility ("CCFF"), subject to the Bank of England approving relevant documentation.

Outlook

With the health and safety of our colleagues remaining our top priority, the phased return to production is underway, to support our customers and help the UK construction sector get building again.

Current trading conditions remain difficult but the combination of the cost reductions, restructuring measures and improved liquidity have strengthened the Group's ability to meet current challenges and benefit from the eventual recovery in its core markets.

As a result of current unprecedented levels of uncertainty, it is not possible to provide an accurate assessment of the trading outlook for the current year, and accordingly, guidance remains withdrawn.

1 Existing covenants under the Group's RCF facility require: leverage of no more than 3 times net debt to EBITDA; and interest cover of no less than 4 times, tested bi-annually at each reporting date.

The leverage test as at December 2020 will be replaced by a liquidity test requiring the Group to have Minimum Liquidity of £60 million. Liquidity defined as: (Cash and Equivalents) + (Available Existing RCF Commitments) - (Any Outstanding Drawings under the CCFF).

The interest cover test as at December 2020 will be amended to no less than 1.25 times.

The leverage test as at 30 June 2021 will be amended to no more than 3.75 times net debt to EBITDA.

Enquiries to:

Ibstock plc

Joe Hudson, CEO

Chris McLeish, CFO

Robert Coates, Investor Relations Director

07880 486329

Citigate Dewe Rogerson

020 7638 9571

Kevin Smith

Nick Hayns

 

About Ibstock Plc

Ibstock plc is a leading manufacturer of clay bricks and a diversified range of clay and concrete products, from its operations in the United Kingdom. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and pre‐stressed concrete products.

 

The Group's two divisions are:

 

Ibstock Clay: The leading manufacturer by volume of clay bricks sold in the United Kingdom. With 19 manufacturing sites Ibstock Brick has the largest brick production capacity in the United Kingdom. It operates a network of 23 active quarries located close to its manufacturing plants. Ibstock Brick has recently commissioned a new soft mud brick manufacturing plant in Leicestershire that added approximately 100 million bricks to its brick production capacity per annum. Ibstock Kevington provides masonry and pre-fabricated component building solutions, operating from 5 sites across the UK.

 

Ibstock Concrete: A leading manufacturer of concrete roofing, walling, flooring and fencing products, along with lintels and general concrete building products, with 16 manufacturing plants in the United Kingdom.

 

Forward-looking statements

This announcement contains "forward-looking statements". These forward-looking statements include all matters that are not historical facts and include statements regarding the intentions, beliefs or current expectations of the directors. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are difficult to predict and outside of the Group's ability to control. Forward-looking statements are not guarantees of future performance and the actual results of the Group's operations. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Group undertakes no obligation to update or revise publicly any forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKLLFBBQLBBBF
Date   Source Headline
25th Apr 20247:00 amRNSFirst Quarter Trading Update
18th Apr 202411:00 amRNSHolding(s) in Company
11th Apr 20243:05 pmRNSNotice of AGM
4th Apr 20244:15 pmRNSDirector/PDMR Shareholding
25th Mar 202411:00 amRNSDirector/PDMR Shareholding
8th Mar 20244:25 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSPreliminary Results
22nd Jan 202410:00 amRNSHolding(s) in Company
19th Jan 20243:00 pmRNSHolding(s) in Company
17th Jan 20247:00 amRNSTrading Update
8th Jan 20244:09 pmRNSNotification of Trading Update
2nd Jan 20248:26 amRNSHolding(s) in Company
2nd Jan 20248:00 amRNSBlock Listing Six Monthly Return
18th Dec 20233:00 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 20234:30 pmRNSHolding(s) in Company
28th Sep 202310:47 amRNSHolding(s) in Company
26th Sep 202312:32 pmRNSNotification of Trading Statement
25th Aug 20232:00 pmRNSDirector/PDMR Shareholding
15th Aug 20233:30 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSInterim results
3rd Jul 20234:17 pmRNSBlock listing Interim Review
27th Jun 20233:30 pmRNSReport on Payments to Govts
22nd Jun 202312:00 pmRNSHolding(s) in Company
16th Jun 202310:00 amRNSHolding(s) in Company
4th May 20232:57 pmRNSDirector Declaration
2nd May 20232:00 pmRNSDirector/PDMR Shareholding
27th Apr 20232:00 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Trading Update
20th Apr 20232:30 pmRNSDirector/PDMR Shareholding
4th Apr 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 202311:30 amRNSChange in External Directorships
23rd Mar 20232:00 pmRNSAnnual Report and Accounts and Notice of AGM
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
15th Mar 20239:00 amRNSDirectorate Change
8th Mar 20233:30 pmRNSDirectorate Change
8th Mar 20237:00 amRNSPreliminary Results
18th Jan 20237:00 amRNSTrading Update
18th Jan 20237:00 amRNSBlock listing Six Monthly Return
10th Jan 202310:30 amRNSNotification of Trading Statement
8th Dec 20224:55 pmRNSHolding(s) in Company
22nd Nov 202210:00 amRNSChange in External Directorships
10th Nov 20229:30 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 202212:00 pmRNSHolding(s) in Company
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.